融资超3亿！AI血压管理公司完成B轮

Core Viewpoint - Aktiia, now rebranded as Hilo, has developed a continuous, cuffless blood pressure monitoring device that utilizes AI and optical technology, aiming to transform hypertension management globally [2][14]. Group 1: Product Mechanism - Hilo's device is a wrist-worn, non-invasive blood pressure and heart rate monitor that operates continuously and conveniently [4]. - The device employs photoplethysmography (PPG) technology to measure blood pressure and heart rate without the need for cuffs [4][8]. - It features an automatic measurement mechanism that records blood pressure every hour, including during the night, and requires initial and monthly calibration with a standard cuff [7][12]. Group 2: Clinical Performance - Clinical data indicates that Hilo's average systolic and diastolic blood pressure readings during the day are comparable to those obtained from ambulatory blood pressure monitoring (ABPM), which is the clinical gold standard for hypertension diagnosis [8][9]. - User feedback highlights the device's convenience and painlessness, making it more suitable for long-term use, especially for patients who experience anxiety with traditional cuff methods [9]. Group 3: User Experience and Data Services - The device has received CE certification and is approved for sale in 44 countries, with plans to seek FDA approval in the U.S. by 2025 [10][15]. - The accompanying app allows users to track trends, receive personalized recommendations, and share reports with healthcare providers [12]. Group 4: Financing Overview - Hilo completed a $42 million Series B funding round, bringing its total funding to over $100 million, with participation from various investors [11][13]. - The funds will be used for product innovation, clinical iterations, and market expansion in North America, the Middle East, and Asia-Pacific [13]. Group 5: Brand Transformation - The rebranding from Aktiia to Hilo signifies a strategic shift towards a more globally recognized identity, aiming to connect personal health data with clinical applications [14]. - Hilo's vision has expanded from developing AI blood pressure monitoring models to providing comprehensive health management tools for both individuals and enterprises [14]. Group 6: Global Expansion Strategy - Hilo's products have achieved CE certification and are being marketed in multiple countries, with over 120,000 units sold and more than 300 million blood pressure data points collected [15]. - The company is exploring partnerships with insurance companies and telemedicine platforms to enhance its market presence [15][16]. Group 7: Enterprise-Level Path Exploration - Hilo is transitioning from a device manufacturer to a platform company, integrating AI capabilities and wearable data to enhance remote healthcare management [16]. - The continuous monitoring trend aligns with the increasing burden of chronic diseases, positioning Hilo at the forefront of healthcare innovation [16].